Clearmind Medicine (CMND) vs Sunshine Biopharma (SBFM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Clearmind Medicine is the larger company by market cap ($3.3 million vs $1.7 million), about 2.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | CMND | SBFM |
|---|---|---|
| Share price | $6.55 | $0.3934 |
| Market cap | $3.32M | $1.70M |
| 1-day change | -0.76% | -43.80% |
| Forward P/E | — | 0.00 |
| EPS (TTM) | $-461.20 | $-9.45 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3,840.00 | $24.30 |
| 52-week low | $5.25 | $0.356 |
| Distance from 52-week high | -99.83% | -98.38% |
| Average volume | 70.35K | 3.33M |
| Shares outstanding | 507.40K | 4.31M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
CMND vs SBFM FAQ
Which is bigger, Clearmind Medicine or Sunshine Biopharma?
Clearmind Medicine (CMND) is larger, with a market capitalization of $3.32M compared with $1.70M for Sunshine Biopharma (SBFM).
Are Clearmind Medicine and Sunshine Biopharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.